{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:32Z","timestamp":1762507472992,"version":"3.41.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijrobp.2018.07.188","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T16:38:15Z","timestamp":1532536695000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Edith M.T.","family":"Dieleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apollonia L.J.","family":"Uitterhoeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike W.","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob M.","family":"van Os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia G.J.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merel Willemijn","family":"Kolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caro C.E.","family":"Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit A.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J.","family":"Verberne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouke T.","family":"Annema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen R.N.","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.07.188_bib1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib2","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib3","first-page":"CD002140","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","author":"O\u2019Rourke","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cllc.2013.03.002","article-title":"Toxicity of concurrent radiochemotherapy for locally advanced non-small-cell lung cancer: A\u00a0systematic review of the literature","volume":"14","author":"Koning","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-2-27","article-title":"Accelerated high dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with non-small cell lung cancer","volume":"2","author":"Uitterhoeve","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(98)00196-5","article-title":"Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients","volume":"42","author":"Kwa","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/0959-8049(96)00077-9","article-title":"Feasability of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer","volume":"32A","author":"Schuster-Uitterhoeve","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0167-8140(93)90065-G","article-title":"Feasability of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC)","volume":"28","author":"Schuster-Uitterhoeve","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0959-8049(99)00315-9","article-title":"Toxicity of high dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I\/II study. European Organization for Research and Treatment of Cancer","volume":"36","author":"Uitterhoeve","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomized trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2016.02.011","article-title":"Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab","volume":"118","author":"Walraven","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","article-title":"Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer","volume":"59","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cllc.2013.04.001","article-title":"Prediction of acute toxicity grade \u22653 patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin","volume":"14","author":"Uyterlinde","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0360-3016(02)03018-3","article-title":"Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer","volume":"54","author":"Schild","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(92)80128-6","article-title":"Radiotherapy enhanced by cis-platinum in stage III non-small cell lung cancer: A phase II study","volume":"23","author":"Trovo","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2015.64.8824","article-title":"PROCLAIM: Randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer","volume":"34","author":"Senan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2015.05.004","article-title":"Precision hypofractionated radiation therapy in poor performing patients with non-small cell lung cancer: Phase 1 dose escalation trial","volume":"93","author":"Westover","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cllc.2014.08.002","article-title":"Radical-Intent hypofractionated radiotherapy for locally advanced none small-cell lung cancer: A systematic review of the literature","volume":"16","author":"Kaster","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cncr.24732","article-title":"Toxicity report of a phase 1\/2 dose-escalation study in patients with inoperable, locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy","volume":"116","author":"Bral","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fonc.2013.00286","article-title":"Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non\u2013small cell lung cancer","volume":"3","author":"Donato","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2018.07.188_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.12.003","article-title":"The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)","volume":"106","author":"Ball","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618316419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618316419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T01:22:15Z","timestamp":1751764935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618316419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0360301618316419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.07.188","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.07.188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}